GSK-2881078
|
|
|
- CAS-Nr.
- 1539314-06-1
- Englisch Name:
- GSK-2881078
- Synonyma:
- CS-2336;AI300945;AI3 00945;AI3-00945;GSK-2881078;SARM GS2881078;GSK2881078; GSK 2881078;GSK-2881078 (Free base);1-(1-Methylsulfonylpropan-2-yl)-4-(trifluoromethyl)indole-5-carbonitrile;(R)-1-(1-(Methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile
- CBNumber:
- CB43067550
- Summenformel:
- C14H13F3N2O2S
- Molgewicht:
- 330.33
- MOL-Datei:
- 1539314-06-1.mol
|
GSK-2881078 Eigenschaften
- Siedepunkt:
- 521.6±50.0 °C(Predicted)
- Dichte
- 1.36±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- L?slichkeit
- ≤20mg/ml in ethanol;25mg/ml in DMSO;25mg/ml in dimethyl formamide
- Aggregatzustand
- crystalline solid
- Farbe
- White to off-white
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
GSK-2881078 Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
GSK2881078 is a selective androgen receptor modulator (SARM). It induces AR-mediated transcriptional activation in PC3(AR)
2 cells (EC
50 = 3.99 nM), an effect that can be inhibited by the non-steroidal AR antagonist bicalutamide .
Verwenden
GSK 2881078 is a selective androgen receptor modulator which can display agonistic properties in anabolic target tissues
GSK-2881078 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
GSK-2881078 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 95)Lieferanten
- GSK-2881078
- GSK-2881078 (Free base)
- GSK2881078; GSK 2881078
- SARM GS2881078
- CS-2336
- 1H-Indole-5-carbonitrile, 1-[(1R)-1-methyl-2-(methylsulfonyl)ethyl]-4-(trifluoromethyl)-
- 1-[(2R)-1-(Methylsulfonyl)-2-propanyl]-4-(trifluoromethyl)-1H-indole-5-carbonitrile
- 1-(1-Methylsulfonylpropan-2-yl)-4-(trifluoromethyl)indole-5-carbonitrile
- AI3 00945
- AI300945
- AI3-00945
- 1-[(1R)-1-methyl-2-(methylsulfonyl)ethyl]-4-(trifluoromethyl)-1H-indole-5-carbonitrile
- (R)-1-(1-(Methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile
- 1539314-06-1
- 153314-06-1
